Literature DB >> 3914504

Naloxone increases bioactive LH in man: evidence for selective release of early LH pool.

F Fraioli, A Fabbri, L Gnessi, C Moretti, V Bonifacio, A Isidori, M Dufau.   

Abstract

Opioid peptides inhibit LH secretion and the opiate antagonist naloxone provokes increases in plasma LH levels by release of endogenous GnRH from the hypothalamus. To explore the effect of endogenously released GnRH on the mobilization of bioactive LH pools, the bioactive LH response to a single iv bolus dose of 20 mg naloxone has been evaluated and compared to the immunoactive pattern of the hormone in eight young normal male volunteers. Blood samples were withdrawn at 15, 30, 45, 60, 90, 120 min after naloxone injection and LH levels were measured by RIA and rat interstitial cell testosterone (RICT) bioassay. A significant increase in both bio and immuno active LH was observed in all subjects after 15-30 min (p less than 0.05 to p less than 0.001), reaching maximal levels at 30-60 min for both forms of the hormone. The time course of the bioactive LH response magnified the immunoactive LH pattern, and the maximum fold increases were 1.4 and 1.3 fold (62.4 +/- 5.5 SE and 25.0 +/- 3.7 SE mIU/ml) from basal bio and immuno LH levels of 25.9 +/- 4.3 SE and 11.1 +/- 2.0 SE mIU/ml respectively. An early single peak response of bio and immunoactive LH was observed in six subjects while a biphasic pattern was observed in two subjects with a clearly defined and prominent early pool followed by a second pool of higher magnitude. Both bio and immunoactive LH levels began to decline at 45-60 min, but in most subjects remained significantly elevated by about 30% above the basal values at 120 min.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3914504     DOI: 10.1007/BF03348550

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  31 in total

1.  Relation of endogenous opioid peptides and morphine to neuroendocrine functions.

Authors:  J Meites; J F Bruni; D A Van Vugt; A F Smith
Journal:  Life Sci       Date:  1979-04-09       Impact factor: 5.037

2.  Effects of morphine and methadone on serum testosterone and luteinizing hormone levels and on the secondary sex organs of the male rat.

Authors:  T J Cicero; E R Meyer; R D Bell; G A Koch
Journal:  Endocrinology       Date:  1976-02       Impact factor: 4.736

3.  Acute reductions in serum testosterone levels by narcotics in the male rat: stereospecificity, blockade by naloxone and tolerance.

Authors:  T J Cicero; C E Wilcox; R D Bell; E R Meyer
Journal:  J Pharmacol Exp Ther       Date:  1976-08       Impact factor: 4.030

4.  Morphine decreases luteinizing hormone by an action on the hypothalamic-pituitary axis.

Authors:  T J Cicero; T M Badger; C E Wilcox; R D Bell; E R Meyer
Journal:  J Pharmacol Exp Ther       Date:  1977-12       Impact factor: 4.030

5.  Endocrine effects of naloxone-induced opiate receptor blockade.

Authors:  J E Morley; N G Baranetsky; T D Wingert; H E Carlson; J M Hershman; S Melmed; S R Levin; K R Jamison; R Weitzman; R J Chang; A A Varner
Journal:  J Clin Endocrinol Metab       Date:  1980-02       Impact factor: 5.958

6.  Disposition of naloxone: use of a new radioimmunoassay.

Authors:  B A Berkowitz; S H Ngai; J Hempstead; S Spector
Journal:  J Pharmacol Exp Ther       Date:  1975-12       Impact factor: 4.030

7.  In vitro bioassay of LH in human serum: the rat interstitial cell testosterone (RICT) assay.

Authors:  M L Dufau; R Pock; A Neubauer; K J Catt
Journal:  J Clin Endocrinol Metab       Date:  1976-05       Impact factor: 5.958

8.  The role of endogenous opiates in LH secretion during the menstrual cycle.

Authors:  M E Quigley; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1980-07       Impact factor: 5.958

9.  Endogenous opiates modulate the pulsatile secretion of biologically active luteinizing hormone in man.

Authors:  J D Veldhuis; A D Rogol; M L Johnson
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

10.  3H-Leu5-enkephalin specific binding to synaptic membrane-comparison with 3H-dihydromorphine and 3H-naloxone.

Authors:  P Y Law; H H Loh
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1978-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.